












Ira Spector
Founder at SFA Therapeutics
Dr. Spector is the co-founder of SFA, a microbiome-derived pharmaceutical company focused on new advancements in the treatment inflammatory diseases. An experienced drug developer with over 30 years of experience, he helped develop 34 drugs and 12 medical devices, including Enbrel, Effexor, Protonix, Prevenar, Ozurdex, Botox for Overactive Bladder, Chronic Migraine and Cerebral Palsy. He holds BS degrees in Physics and EE from Washington University, an MBA from Drexel, and a PhD from Rutgers.
Follow Ira
Previously at

ICON plc
Allergan Pharmaceutical
Allergan
Wyeth/Pfizer

Pfizer

PA Consulting Group
Mars Electronics, Inc.

Mars Electronics
Air Products & Chemicals, Inc.

Air Products and Chemicals
Alumnus of
University of Medicine & Dentistry of NJ (UMDNJ, now Rutgers University)
Drexel University
Washington University, St. Louis